An observational study in Osteoarthritis, Knee and Joint Instability, sponsored by Peter Brehm GmbH. Terminated at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-20.
Sponsored by Peter Brehm GmbH · Observational
Prospective, monocenter post market clinical follow-up of a primary knee replacement bearing the CE-mark.
200 subjects will be recruited and followed up for up to ten years or until revision of the primary knee endoprosthesis, whichever occurs first. Documentation of clinical and radiological parameters within the clinical routine pre-operative and post-operative at 3 and 12 months and 2, 5 and 10 years to evaluate time to revision, pain situation, knee functionality, mobility and stability.
Patients undergoing primary total knee endoprosthesis with BPK-S Integration of age 18 and older
Exclusion Criteria:
Time until revision
Time frame: 10 years
Improvement of clinical situation based on Knee Society Score
Time frame: 3 and 12 months, 2, 5, 10 years
Documentation of incidents
Time frame: Up to 10 Years
This study is terminated, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peter Brehm GmbH